HYGIENE COMPOSITIONS WITH INVERSE EMULSION POLYMERS
This invention relates to use of inverse emulsion polymers having improved electrolyte tolerance and efficiency as emulsifiers, thickeners and stabilizers in personal care compositions. The compositions have excellent shear, shelf and use stability, as well as excellent formulation aesthetics (such as skin feel, residue, moisturizing, emolliency, rub-in, absorption and adsorption characteristics, and the like). Personal care compositions include after-shave balms, barrier creams, skin whitening compositions, anti-aging creams and lotions, skin moisturizers, cleansers, color cosmetic compositions, foundations, hair conditioners, hair creams and lotions, moisturizers, pomades, sunscreens, toners, and the like. Such compositions can be applied to the skin or hair as creams or lotions (typically as oil-in-water emulsions and sometimes as water-in-oil emulsions), gels (typically containing substantial quantities of water miscible alcohols or glycols), mousses, ointments, pads, pastes, solutions, sprays, sticks (as defined in Both natural and synthetic materials have been used to modify rheological properties of personal care compositions. Natural materials (such as gum arabic, guar gum, starches and modified starches, and the like) vary widely in quality and thus also in thickening properties. They tend to be prone to microbial attack, which leads to products having limited shelf life. Synthetic materials are used more commonly, since they can be made with more consistent quality and better stability. Synthetic materials used as thickeners in personal care compositions include solid precipitation polymers that generally must be dispersed and have residual acid groups that must be neutralized in order to become effective. Alkali swellable emulsion polymers that are liquid can be more easily mixed in personal care compositions but also have residual acid groups that must be neutralized before such addition. Inverse emulsion polymers are well known as thickeners in personal care compositions and typically are provided as a water-in-oil emulsion, i.e., a water-dispersible polymer in water that is emulsified in a continuous oil phase. When the inverse emulsion polymer is added to water during preparation of the personal care composition the water phase becomes the continuous phase, and the polymer expands through the water phase to thicken and give stability to the now reversed, oil-in-water, creamy white emulsion. U.S.-A- 5,216,070 relates to formation of a water-in-oil emulsion of a water-soluble polymer by emulsion polymerization of a 65-85% neutralized water-soluble unsaturated carboxylic acid monomer using a polysiloxane polyalkylene polyether copolymer as an emulsifier. The emulsion remains stable during the course of the polymerization, even though the polymer was not fully neutralized, and can be diluted easily with an aqueous system to invert the emulsion to a neutral oil-in-water emulsion that is useful together with various active ingredients for personal care products. U.S.-A- 6,051,245 relates to a thickener for personal care products comprising units derived from (a) acrylamide, (b) 2-acrylamido-2-methylpropane-sulfonic acid (AMPS), and (c) a polyfunctional crosslinking monomer present in an amount of from 0.12 to 2 milliequivalents inclusive per mole of total monomer units. Preferred crosslinking monomers are allyl sucrose, allyl pentaerythritol, and N,N1-methylene-bisacrylamide (MBA). U.S.-A- 6,136,305 relates to a thickener comprising a water-in-oil emulsion and a copolymer having moieties derived from (i) a monounsaturated monocarboxylic acid monomer containing from 3 to 5 carbon atoms, the monocarboxylic acid either being in free form or in the form of an inorganic salt, and (ii) a monoacrylamide monomer. The copolymer is in solution in the aqueous phase constituting the emulsion, and the oil phase consists of a mixture of at least one volatile oil and at least one non-volatile oil in a weight ratio between 90/10 and 10/90. US-A-6,136,328 relates to a composition in the form of an oil-inwater emulsion with a high electrolyte content, comprising a continuous aqueous liquid phase, a non-aqueous phase and an emulsifying system preferably having an HLB value of greater than or equal to 9. The emulsion may also contain adjuvants, active agents intended in particular to prevent and/or treat skin complaints. The personal care emulsion for topical application described does not contain an electrolyte tolerant inverse emulsion polymer. WO-A-99/15144 relates to oil-in-water sunscreen compositions and to a method for improving the stability of emulsions employing carboxylic acid polymers, e.g. carbomers and C10-C30 alkyl acrylates, by neutralizing these polymers with amino methyl propanol and/or DEA-cetyl phosphate. The compositions may further comprise secondary thickening agents, e.g. polyacrylamide and C13-14 isoparaffin and laureth-7, available as Sepigel™, and polymers for aiding the film-forming properties and substantivity of the composition such as copolymer of eicosene and vinyl pyrrolidone. The emulsions described comprise emulsifiers such as Polysorbate 80, surfactants, adjuvants and crosslinkers. EP-A-1059305 relates to inverse emulsion polymers that are useful in personal care compositions comprising a copolymer or copolymer salt of N,N,-dimethylacrylamide and 2-acrylamido-2-methylpropane sulfonic acid or acid salts in an inert hydrocarbon liquid organic dispersion medium wherein the composition contains an emulsifier/primary surfactant, a chain transfer agent and a cross-linker. Inverse emulsion polymers of the prior art often have defects. For example, inverse emulsion polymers often contain volatile solvents in the oil phase. Volatile solvents are undesirable because of contribution to air pollution, irritation, and possible toxic effects. Additionally, inverse emulsion polymers tend to have poor electrolyte tolerance. Many adjuvants and formulation aids utilized in personal care compositions are ionic or electrolytic in character. For example, many naturally occurring biologically active and botanical extract adjuvants (e.g., borage extract, black walnut, bee pollen, alfalfa, ginseng, and sea kelp) contain monovalent and/or divalent ions. Poor electrolyte tolerance means that when these ingredients and other electrolyte containing components are added to the inverse emulsion polymer containing personal care composition, the increased ionic or salt content deleteriously affects the thickening ability (i.e., efficiency) of the polymer. Lower efficiency of the polymer system means that more polymer is required to offset the decreased thickening ability of the polymer. Prior art inverse emulsion polymers also tend to be sensitive to shear. Upon exposure to excessive shear such as homogenization, the prior art emulsions tend to become unstable, i.e., the oil and water phases begin to separate. This lack of stability leads to shorter shelf life and use life of the personal care composition. Special equipment that avoids excessive shear (more than 4,500 rpm) must be used during manufacture of the prior art personal care compositions. Improved personal care compositions are desired. They must have excellent shear, shelf and use stability, as well as excellent formulation aesthetics (such as skin feel, residue, moisturizing, emolliency, rub-in, and absorption and adsorption characteristics, and the like). Accordingly, it is a general object of this invention to provide personal care compositions that are formulated with inverse emulsion polymers having improved electrolyte tolerance, higher efficiency and function as improved emulsifiers, thickeners and stabilizers. This invention relates to use of inverse emulsion polymers to develop personal care compositions having excellent shear, shelf and use stability, as well as excellent formulation aesthetics (such as skin feel, residue, moisturizing, emolliency, rub-in, and absorption characteristics, and the like). Such personal care compositions are made using inverse emulsion polymers having improved electrolyte tolerance and higher efficiency and that function as improved emulsifiers, thickeners and stabilizers. The personal care compositions comprise (A) topically acceptable liquid phases, and (B) at least one inverse emulsion polymer having a pH from about 5.5 to about 8 and comprising the reaction product of: In particular, the invention is related to a personal care emulsion composition for topical application to the skin comprising: Preferred embodiments will become evident from the attached claims and the detailed description. In one aspect of the present invention, the personal care compositions of the present invention comprise (A) a topically acceptable liquid phase, and (B) at least one inverse emulsion polymer having a pH from 5.5 to 8 and comprising the polymerization product of a monomer composition comprising: It is to be recognized that the amount of each of components (1), (2), (3), and (4) is selected from the disclosed range such that the amount of monomer in the polymerizable monomer composition adds up to 100 wt. %. As used herein, the term "wt. %" means the number of parts by weight of monomer per 100 parts by weight of monomer in the reaction mixture, or the number of parts by weight of ingredient per 100 parts by weight of personal care composition. The complex associative monomer used in preparing the inverse emulsion polymers typically is a compound including in each molecule: (a) ethylenic unsaturation in an end group for addition polymerization with the other monomers described hereinafter. The complex associative monomer includes a pendant moiety having (b) a hydrophilic portion in the midsection that terminates with (c) a hydrophobic tail portion. The term "complex" means that the monomer is not only hydrophilic or hydrophobic but both hydrophilic and hydrophobic. The term "associative" means that the pendant moiety of the repeating unit polymerized from the complex associative monomer is capable of non-covalent bonding with other portions of the polymer or other ingredients in the personal care composition. Without wishing to be bound by theory of invention it is believed that the non-covalent bonding occurs through hydrogen bonding, Van der Waals forces, etc. The moiety (a) supplying the vinyl or other ethylenically unsaturated end group for addition polymerization typically is derived from an α,β-ethylenically unsaturated mono or di-carboxylic acid or the anhydride thereof, preferably a C3 or C4 mono- or di-carboxylic acid or the anhydride thereof. Alternatively, this moiety can be derived from an allyl ether or vinyl ether; a nonionic urethane monomer, such as disclosed in U.S. Reissue Patent No. 33,156 or U.S.-A- 5,294,692; or a urea reaction product, such as disclosed in U.S.-A- 5,011,978. Also included in the chemical structure of each associative monomer molecule is a pendant moiety comprising midsection (b) having a long-chain hydrophilic segment. Typically this midsection comprises a polyoxyalkylene segment of 10 to 250 linear and branched C2 to C7 alkylene oxide repeating units. In another aspect the number can range from 10 to 120 repeating units, and in a further aspect 10 to 60 repeating alkylene oxide repeating units. In still another aspect of the invention, midsections include polyoxyethylene segments, polyoxypropylene segments, and segments comprising mixtures of ethylene oxide and propylene oxide units, all segments comprising 10 to 150 repeating units. In another aspect 10 to 100 repeating units, and in a still further aspect 10 to 60 ethylene oxide units, propylene oxide units, or mixtures of ethylene oxide or propylene oxide units. The mixture of ethylene oxide and propylene oxide units can be random or non-random (e.g., block) sequences. Examples of associative monomers include those represented by formula I: Examples of preferred associative monomers include lauryl polyethoxylated methacrylate, palmityl polyethoxylated methacrylate, cetyl polyethoxylated methacrylate, cetylstearyl polyethoxylated methacrylate, stearyl polyethoxylated methacrylate, tristearylphenol polyethoxylated methacrylate, arachidyl polyethoxylated methacrylate, behenyl polyethoxylated methacrylate, cerotyl polyethoxylated methacrylate, montanyl polyethoxylated methacrylate, melissyl polyethoxylated methacrylate, and lacceryl polyethoxylated methacrylate. In one aspect of the invention the foregoing polyethoxylated monomers contain from 10 to 100 ethylene oxide units. In another aspect the polyethoxylated monomers contain from 10 to 60 ethylene oxide units, and in a further aspect contain from 10 to 30 ethylene oxide units. The amount and ratio of complex associative monomer in the inverse emulsion polymer can vary and depends, among other things, on the final properties desired for the polymer and the process stability. If too much complex associative monomer is used, the polymer becomes too expensive to be practical, and polymerization does not proceed in a stable fashion, producing gels, grits, and the like. For most applications, the amount of complex associative monomer introduced in the reaction mixture for the inverse emulsion polymer should range from 0.0001 wt. % to 3 wt. % based on the total weight of monomer in the reaction mixture. In another aspect the amount of complex associative monomer can range from 0.0001 wt. % to 0.9 wt. % based on the total weight of monomer in the reaction mixture. In another aspect the amount of complex associative monomer can range from 0.001 wt. % to 0.75 wt %, and in a further aspect from 0.001 wt. % to 0.5 wt. % based on the total weight of the monomer in the reaction mixture. In a still further aspect the amount of monomer can range from 0.001 to 0.25 wt. % based on the total weight of the monomer in the polymerizable monomer composition. The inverse emulsion polymer has polymerized therein at least one pH sensitive monomer having ethylenic unsaturation and containing at least one carboxylic acid group. Alternatively, an optional pH sensitive monomer having ethylenic unsaturation and a sulfonic acid group can be copolymerized with the carboxylic acid containing monomer into the inverse emulsion polymer backbone. If utilized, the amount of sulfonic acid containing monomer employed can range from 1 wt. % to 30 wt. % of the total pH sensitive monomer in the polymerizable monomer composition. In another aspect of the invention, the amount of sulfonic acid monomer employed can range from 5 wt. % to 10 wt. % of the total pH sensitive monomer in the polymerizable monomer composition. Prior to polymerization, the pH sensitive monomers are neutralized, i.e., the free carboxylic acid groups and the free sulfonic acid groups (if present) are converted to a salt. In one aspect of the invention, 50 to 100 wt. % of the free acid containing monomers are neutralized. In another aspect 60 to 100 wt. % of the free acid containing monomers are neutralized, and in a further aspect 75 to 95 wt. % of the pH sensitive monomers are neutralized. Salts of the pH sensitive monomers can contain any suitable monovalent cation capable of forming a salt with the free carboxylic or free sulfonic acid moiety contained in the monomer. The salts can readily be formed by reacting the free carboxylic acid and free sulfonic acid containing monomers with a cation containing neutralizing base. Suitable bases include but are not limited to, alkali metal (e.g., sodium, potassium, lithium) hydroxides and carbonates, ammonium hydroxide and amine salts. The term "pH sensitive" means that the charge of the monomer is pH dependent and can change from a neutral molecule to a charged molecule. Suitable carboxylic and sulfonic acid groups include monoacids, diacids, anhydrides of carboxylic acids, half esters of diacids, and the like. A wide variety of carboxyl-based vinyl monomers can be used. Examples of such monomers include, but are not limited to, acrylic acid, methacrylic acid, itaconic acid, citraconic acid, maleic acid, fumaric acid, crotonic acid, and C1-C4 alkyl half esters of maleic and fumaric, itaconic acid or aconitic acid, such as methyl hydrogen maleate, monoisopropyl maleate and butyl hydrogen fumarate, and the like, and mixtures thereof. In one aspect of the invention, acrylic acid, methacrylic acid, fumaric acid and itaconic acid in mono- or di-acid form, are utilized because of their availability. Examples of sulfonic acid containing monomers include 2-acrylamido-2-methylpropane sulfonic acid (available as AMPS® from The Lubrizol Corporation), sodium p-styrene sulfonate (available as Spinomar® from The Lubrizol Corporation), sulphoethyl methacrylate, and the like, and mixtures thereof and with the carboxyl-based vinyl monomers. In one aspect of the invention, the pH sensitive monomer introduced into the monomer reaction mixture. for the inverse emulsion polymer ranges from 25 wt. % to 99.9998 wt. % based on the total weight of the monomer in the monomer reaction mixture. In another aspect, the monomer is present in a range from 60 wt. % to 99.998 wt. %, and in a further aspect from 89.998 wt. % to 99.998 wt. %. based on the total weight of monomer in the reaction mixture. The inverse emulsion polymer has optionally polymerized therein at least one addition copolymerizable non-ionic monomer. Examples of such non-ionic monomers include C2-C6 hydroxy alkyl acrylates and methacrylates, C2-C6 amino alkyl esters of acrylic and methacrylic acids, glycerol monomethacrylate, tris(hydroxymethyl) ethane monoacrylate, pentaerythritol monomethacrylate, N-hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, acrylamide, hydroxypropyl methacrylamide, vinyl caprolactam, N-vinyl pyrrolidone, C1-C4 alkoxy substituted methacrylates and methacrylamides such as methoxyethyl methacrylate, 2(2-ethoxyethoxy)ethyl methacrylate, polyethylene glycol mono methacrylate and polypropylene glycol mono methacrylate, and the like, and mixtures thereof. Acrylamide is preferred. In one aspect of the invention, the non-ionic monomer introduced in the reaction mixture for the inverse emulsion polymer ranges from 0 wt. % to 74.9998 wt. % of the total weight of monomer in the monomer reaction mixture. In another aspect from 1 wt. % to 39.998 wt. %, and in a further aspect from 1 wt. % to 10 wt. %. based on the total weight of monomer in the reaction mixture. The inverse emulsion polymer has polymerized therein at least one polyfunctional crosslinking monomer. By polyfunctional is meant that the crosslinking monomer contains at least two terminal ethylenically unsaturated groups, e.g., CH2=CH-. Examples of suitable crosslinking monomers include any polyene, such as decadiene or trivinyl cyclohexane; acrylamides, such as methylene bis acrylamide; polyfunctional acrylates, such as trimethylol propane triacrylate; polyfunctional vinylidene monomers containing at least 2 terminal CH2=CH- groups, such as butadiene, isoprene, divinyl naphthalene, allyl acrylates and the like; allyl esters, allyl ethers, diallyl esters, dimethallyl ethers, allyl and methallyl acrylates, tetravinyl silane, polyalkenyl methanes, diacrylates, triacrylates, dimethacrylates, trimethacrylates and tetramethacrylates; divinyl compounds such as divinyl benzene, polyallyl phosphate, diallyloxy compounds and phosphite esters, and the like, and mixtures thereof. Examples of specific crosslinking monomers include allyl pentaerythritol, methylene bis acrylamide, allyl sucrose, trimethylolpropane triacrylate, trimethylolpropane trimethacrylate, 1,6-hexanediol diacrylate, trimethylolpropane diallyl ether, pentaerythritol triacrylate, tetramethylene dimethacrylate, ethylene diacrylate, ethylene dimethacrylate, triethylene glycol dimethacrylate, and the like. Preferred crosslinking monomers include methylene bis acrylamide, allyl pentaerythritol, trimethylolpropane diallylether, and allyl sucrose. In one aspect of the invention, the crosslinking monomer introduced in the reaction mixture for the inverse emulsion polymer ranges from 0.0001 wt. % to 2 wt. % based on the total weight of monomer in the monomer reaction mixture. In another aspect the amount ranges from 0.001 wt. % to 1 wt. %, and in a further aspect from 0.001 to 0.1 wt. % based on the total weight of monomer in the reaction mixture. The pH sensitive monomer is dispersed in water and neutralized to the desired level (at least 65 % by wt. of the total amount of pH sensitive monomer in the polymerizable monomer composition) by addition of a suitable neutralizing base, e.g., ammonium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate. Other ingredients such as chelating agents, chain-transfer agents, comonomers (the complex associative monomer, other pH sensitive monomers, the optional copolymerizable non-ionic monomer, crosslinking monomer, described above) and additional water can be added before, during, or after neutralization. If desired, these ingredients can be added after the water phase is mixed with the oil phase. Alternatively, one or more of these ingredients can be added or metered into the polymerization medium during the polymerization reaction. Chelating agents that chelate transition metal ions can be added to the water phase. Examples of such compounds include ethylene-diamine tetracetic acid (EDTA) and salts thereof, diethylene triamine pentaacetic acid (DTPA) and salts thereof, ethylene diamine tetramethylene phosphonic acid and salts thereof, citric acid and salts thereof, gluconic acid and salts thereof, Goodrite® 3000X15 chelator available from Noveon, Inc., and mixtures thereof. It is known that the incorporation of chain transfer agents depresses the molecular weight of the polymer and or alters the molecular structure of the polymer. When desired a small amount of chain transfer agent can be added to the polymerization mixture. Suitable compounds include lower alcohols such as methanol or isopropanol, butylene glycol, phosphate compounds such as sodium hypophosphite, thiol containing monomers, such as 2-mercaptoethanol, 3 mercaptopropionic acid, thioglycolic acid, and formic acid, and the like, and mixtures thereof. The optimum amount required to give chosen polymer properties can be determined by experiment and will depend on, inter alia, the chain transfer agent that is being used. Typically the amount of chain transfer agent employed ranges from 0.001 wt. % to 1% based on total weight of monomer in the reaction mixture. Oil is placed in a reactor equipped with a mechanical stirrer, a thermocouple, and a nitrogen inlet. A suitable amount of low HLB (3 to 6.9) surfactant or mixture of low HLB surfactants can be mixed into the oil. Suitable low HLB surfactants include, but are not limited to, ethoxylated saturated C12-C22 acid alcohols, ethoxylated unsaturated C12-C22 acid alcohols, C8-C22 alcohol ethoxylates, ethoxylated vegetable derived oils, ethoxylated vegetable derived esters, vegetable derived esters, ethoxylated C8-C22 fatty acids, silicone glycol copolymers, esters of sorbitol, ethoxylated esters of sorbitol, block copolymers of ethyleneoxide/propyleneoxide, and alkyl phenol ethoxylates. Other suitable low HLB surfactants for inverse emulsion polymerization are well known to those skilled in the art and include surfactants such as those listed in U.S.-A- 4,650,827 (see column 4, lines 46-60), as well as those low HLB surfactants listed on pages 249, 250, 251, and 252 of Suitable oils for use in the oil phase are various types of water inert insoluble organic liquids. Personal care grade mineral oils, such as Carnation® white mineral oils, Petro-Canada Oils, Witco Chemical light mineral oils, Drakeol® mineral oils from Penreco Inc., polyisobutene, isohexadecane, caprylic/capric triglycerides, cetearyl octanoate, C12-C14 alkyl benzoate, vegetable oils, and the like, having specific gravity in the range of 0.78 to 0.95 at 25°C and a distillation point at of 160°C or higher. While the oil phase is being agitated, the water phase is added to the oil phase. Depending on the particle size and size distribution desired, a high shear mixing device such as a homogenizer or a blender can be used to make the water-in-oil emulsion. The polymerization reaction is carried out under inert atmosphere conditions with minimal exposure to oxygen. Polymerization is conducted using a free radical initiator to start the polymerization. Both water-soluble free radical initiators, such as persulfates, and oil-soluble free radical initiators, such as azo and peroxide thermal initiators, can be used. If a low temperature initiation is desired, then a redox free radical initiation system also can be used. A suitable amount of initiator, typically 0.001 wt. % to 1 wt. % based on the total weight of monomers in the reaction mixture is added. The polymerization is continued until no appreciable heat is released from the polymerization. Additional initiator(s) can be introduced into the reaction vessel in order to further drive the monomer conversion to completion. The conversion of monomer to polymer is essentially quantitative. In other words, each mole of monomer is essentially completely converted to polymer. Monomer conversion is 99 % or greater. Surprisingly and unexpectedly, the foregoing inverse emulsion polymer composition demonstrates an improvement in electrolyte or salt tolerance when used in topical personal care compositions containing monovalent and or divalent electrolytes. Many adjuvants and formulation aids utilized in personal care compositions contain mono- and divalent electrolytes. Electrolytes are deleterious to the emulsifying, stabilizing and thickening properties of inverse emulsion polymers contained in personal care compositions. Electrolyte or salt tolerance is defined herein as the ability of the polymer to maintain a substantial viscosity and emulsion stability when a substantial amount of monovalent or divalent ions are added to the composition (See Tables 17, 18, 19, and 20 in the examples). In one aspect the inverse emulsion polymer(s) of the present invention maintains at least 50 % of its original or initial viscosity when 0.1 wt. % of NaCl is added to 1 wt. % of polymer in deionized water (w/w). In further aspect the polymer(s) maintains 60 % of its original viscosity, and in a still further aspect the polymer(s) maintains 70 % of its original viscosity when about 0.1 wt. % of NaCl is added to 1 wt. % of polymer in deionized water (w/w basis). In another aspect of the invention the instant inverse emulsion polymer(s) maintains at least 25% of its original or initial viscosity when 0.25 wt. % of NaCl is added to 1 wt. % of polymer in deionized water (w/w basis). In another aspect the polymer(s) maintains 40% of its original viscosity, and in a still further aspect the polymer(s) maintains 50% of its original viscosity when 0.25 wt. % of NaCl is added to 1 wt. % of polymer in deionized water (w/w basis). Methods for determining the salt tolerance of the polymers of the present invention are discussed below. One aspect of the present invention concerns an electrolyte tolerant personal care composition that has improved shear, shelf and use stability, as well as excellent formulation aesthetics (such as skin feel, residue, moisturizing, emolliency, rub-in, and absorption characteristics, and the like). The topically acceptable composition of the present invention is described below. The term "topically acceptable composition" means a composition comprising an aqueous phase, non-aqueous phase, high HLB surfactant(s), inverse emulsion polymer composition and personal care adjuvants and/or a formulation aid(s) that may be applied directly to the body. The personal care adjuvant(s) can be carried in the aqueous phase, in the non-aqueous phase or in both the aqueous and the non-aqueous phases. The oil phase and aqueous phase utilized to prepare the inverse emulsion polymer(s) of the invention serve as the base phases for the non-aqueous and aqueous phases of the personal care compositions of the invention. Additional non-aqueous (e.g., oils, non-aqueous solvent, etc.) and aqueous phase (e.g., water, distilled water, deionized water, etc,) components are optionally incorporated into the personal care compositions as diluents and/or carriers for the personal care adjuvant(s) and formulation aid(s) described below. The non-aqueous phase can include any composition of water immiscible substances known to those skilled in the art. Non-aqueous phase components include but are not limited to oils and solvents derived from synthetic or natural origin, such as oils derived from plants and vegetables (e.g. sunflower seed oil, hydrogenated castor seed oil), silicone oils, fluorinated hydrocarbon oils, hydrocarbon oils, mineral oils (white mineral oils, Petro-Canada Oils, light mineral oils, Drakeol® mineral oils from Penreco Inc), polyisobutene, hydrogenated polyisobutylene, isohexadecane, caprylic/capric triglycerides, cetearyl octanoate, C12-C15 alkyl benzoate, and mixtures thereof. This phase can contain a water immiscible personal care adjuvant(s) and/or formulation aid(s) described below that can be suspended, dispersed, solubilized, or have the property of miscibility in the non-aqueous phase. In one aspect of the invention, the non-aqueous phase typically comprises 1 wt. % to 90 wt. % of the personal care composition. In another aspect the non-aqueous phase is present from 1 wt. % to 80 wt. %, and in a further aspect 5 wt. % to 70 wt. % of the personal care composition. The aqueous phase includes water and can contain a personal care adjuvant(s) and/or formulation aid(s) described below that are soluble, suspendable, dispersible, swellable, or miscible in the aqueous phase. In one aspect of the invention, the aqueous phase comprises from 10 wt. % to about 99 wt. % of the personal care composition. In another aspect from 20 wt. % to 99 wt. % and in a further aspect from 30 wt. % to 95 wt. % of the personal care composition. A personal care adjuvant comprises a substance that imparts a desired personal care property to the topical composition. Personal care adjuvants include but are not limited to humectants, emollients, fragrances, biologically active materials, botanical extracts, conditioners, sunscreens, pharmaceutical actives, conditioning polymers, vitamins, cleansing surfactants, and the like. In addition to personal care adjuvants, one or more optional formulation aids can be included in the topically acceptable composition. These ingredients include, but are not limited to, preservatives, opacifiers, rheology modifiers, emulsifiers, chelating agents, neutralizing agents and pH adjusters, spreading aids, viscosity adjusters, and colorants as well as numerous other optional components for enhancing and maintaining the properties of the personal care compositions. High HLB surfactant(s) can be added in order to aid the water in oil emulsion to accept water and release the polymer to the formulation continuous phase (i.e. water). High HLB surfactants are those having a HLB number of 7.5 or greater as defined in Exemplary skin care compositions utilizing personal care adjuvants and formulation aids are disclosed in U.S.-A- 5,073,372; 5,380,528; 5,599,549; 5,874,095; 5,883,085; 6,013,271; and 5,948,416. Such components are also described in detail in well known references such as Mitchell C. Schlossman, To those skilled in the art it is known that emulsifiers may serve multiple functions typical of the personal care adjuvants described above. Emulsifiers can function as emollients and delivery vehicles for components of the personal care compositions in addition to the intended purpose of altering the surface tension of water. Emulsifiers have a balance of hydrophilic and lipophilic properties such that they are often found at the interface of the non-aqueous phase and the aqueous phase, sharing the properties of both phases. The above described non-aqueous phase, aqueous phase, high HLB surfactant(s), one or more personal care adjuvants and one or more optional formulation aids are combined with the salt tolerant inverse emulsion polymer composition to form the desired personal care composition. The amount of inverse emulsion polymer (i.e., neat polymer) in the topically acceptable personal care composition ranges from 0.01 wt. % to 10 wt. % of the total weight of the personal care composition. In another aspect the amount of polymer can range from 0.01 wt. % to 8 wt. %, and in a further aspect from 0.1 wt. % to 5 wt. % of the total weight of personal care composition of the present invention. The balance of the personal care composition comprises a non-aqueous phase, an aqueous phase, emulsifier, personal care adjuvants and optional formulation aids. Personal care compositions are well known to those skilled in the art and include after-shave balms, barrier creams, skin whitening compositions, anti-aging emulsions, skin moisturizers, cleansers, color cosmetic compositions, foundations, hair conditioners, hair creams and lotions, moisturizers, pomades, sunscreens, toners, and the like. Such compositions can be applied to the skin or hair as creams, gels, mousses, ointments, pads, pastes, solutions, sprays, sticks, and the like. These compositions typically are formulated as creams or lotions (oil-in-water emulsions and sometimes water-in-oil emulsions), gel creams, or as gels that can contain substantial quantities of water miscible alcohols or glycols. The inverse emulsion polymers described heretofore function as emulsifiers, thickeners and stabilizers to modify rheological properties and to improve stability of the personal care compositions. Humectants are defined as materials that absorb or release water vapor, depending on the relative humidity of the environment, An emollient is defined as a substance which regulates the rate and quantity of water uptake by the skin ( The linear volatile silicones typically have viscosities of less than 5 cP at 25°C., while the cyclic volatile silicones typically have viscosities of less than 10 cP at 25°C. "Volatile" means that the silicone has a measurable vapor pressure. A description of volatile silicones can be found in Todd and Byers, "Volatile Silicone Fluids for Cosmetics", Pharmaceutical actives that can be included in the topically acceptable personal care composition can be selected from any chemical substance, material or compound suitable for topical administration and induces a desired pharmacological local or systemic effect. Such actives include, but are not limited to, antibiotics, antiviral agents, analgesics (e.g. ibuprofen, acetyl salicylic acid, naproxen, and the like), antihistamines, anti-inflammatory agents, antipruritics, antipyretics, anesthetic agents, diagnostic agents, hormones, antifungals, antimicrobials, cutaneous growth enhancers, pigment modulators, antiproliferatives, antipsoriatics, retinoids, anti-acne medicaments (e.g., benzoyl peroxide, sulfur, and the like), antineoplastics agents, phototherapeutic agents, and keratolytics (e.g. resorcinol, salicylic acid, and the like), and the like, and mixtures thereof. When utilized the pharmaceutical active typically comprises from 0.1 wt. % to 20 wt. % of the total weight of the personal care compositions of the present invention. Botanical extracts are defined as extracts from botanicals that can be obtained via various preparations including tincture, fluid extract, solid extract, powdered extract, homeopathic dilution, oil extract, native extract, aqueous extract, and the like. Properties of these preparations are described in Suitable sunscreens that can be included in the topically acceptable personal care composition must be used in safe and photoprotectively effective amounts in the personal care compositions of the present invention. Exemplary sunscreens include those set forth in Segarin et al., By "safe and photoprotectively" is meant an amount of sunscreen sufficient to provide photoprotection when the composition is applied, but not so much as to cause any side effects such as skin reactions. When employed in the compositions of the present invention the sunscreens comprise from 0.5 wt. % to 50 wt. %, of the total weight of the skin care compositions. In another aspect from 0.5 wt. % to 30 wt. %, and in a further aspect from 0.5 wt. % to 20 wt. % of the total weight of the skin care compositions of the present invention. Exact amounts will vary depending upon the sunscreen chosen and the desired amount of Sun Protection Factor (SPF). SPF is a commonly used measure of photoprotection of a sunscreen against erythema. This number is derived from another parameter, the minimal erythemal dose (MED). MED is defined as the least exposure dose at a specified wavelength that will elicit a delayed erythema response. The MED indicates the amount of energy reaching the skin and the responsiveness of the skin to the radiation. The SPF of a particular photoprotector is obtained by dividing the MED of protected skin by the MED of unprotected skin. The higher the SPF, the more effective the agent in preventing sunburn. The SPF value tells how many times longer a person can stay in the sun with use of the sunscreen (compared to the same person with unprotected skin) before that person will experience 1 MED. For example, utilizing a sunscreen with an SPF of 6 will allow an individual to stay in the sun six times longer before receiving MED. As the SPF value of a sunscreen increases, a lesser chance exists for development of tanning of the skin. Cleansing surfactants that can be included in the topically acceptable personal care composition include a wide variety of nonionic, cationic, anionic, and zwitterionic surfactants, such as those disclosed in Suitable zwitterionic cleansing surfactants for use in the present personal care compositions include, but are not limited to, linear and branched C8-C18 aliphatic quaternary ammonium, phosphonium, and sulfonium compounds that include a substituent having an anionic water-solubilizing group, such as carboxy, sulfonate, sulfate, phosphate, phosphonate, and the like. Classes of zwitterionics include alkyl amino sulfonates, alkyl betaines and alkyl amido betaines, stearamido propyl dimethyl amine, diethyl amino ethyl stearamide, dimethyl stearamine, dimethyl soyamine, soyamine, myristyl amine, tridecyl amine, ethyl stearylamine, N-tallowpropane diamine, ethoxylated (5 moles ethylene oxide) stearylamine, dihydroxy ethyl stearylamine, arachidylbehenylamine, and the like. Mixtures of the foregoing can also be used. In one aspect of the invention the cleansing surfactants, comprise from 0 wt. % to 25 wt. %, of the total weight of the personal care composition. In another aspect the amount ranges from 0.5 wt. % to 20 wt. %, and in a further aspect from 1 wt. % to 12 wt. % of the total weight of the personal care compositions of the present invention. Skin conditioning polymers that can be included in the topically acceptable personal care composition include, but are not limited to, quaternized guar gum, quaternized cellulosics, polyquatemium 4, polyquaternium 7, polyquaternium 10, polyquatemium 11, polyquaternium 39, polyquaternium 44, and the like, and mixtures thereof. In one aspect of the invention, the conditioning agents, if present, comprise 0.01 wt. % to 3 wt. % of the total weight of the personal care composition. In another aspect the amount can range from 0.1 wt. % to 2 wt. %, and in a further aspect from 0.1 wt. % to 1 wt. % of the total weight of the skin care compositions of the present invention. Various vitamins that can be utilized in the topically acceptable personal care composition include, but are not limited to vitamin A, vitamin B, biotin, pantothenic acid, vitamin C, vitamin D, vitamin E, tocopherol acetate, retinyl palmitate, magnesium ascorbyl phosphate, and the like, and derivatives, and mixtures thereof. In one aspect of the invention the amount of vitamin(s) that can be employed in the personal care compositions of the invention range from 0.001 wt. % to 5 wt. % of the total personal care composition. In another aspect the amount can range from 0.01 wt. % to 2 wt. %, and in a further aspect 0.1 wt. % to 1 wt. % of the total personal care composition. Chelating agents that can be utilized in the topically acceptable personal care composition include, but are not limited to, EDTA (ethylenediamine tetraacetic acid) and salts thereof such as disodium EDTA, citric acid and salts thereof, cyclodextrins, and the like, and mixtures thereof. In one aspect of the invention, chelating agents comprise from 0.001 wt. % to 3 wt. % of the personal care composition of the invention. In another aspect the amount can range from 0.01 wt. % to 2 wt. %, and in a further aspect from 0.01 wt. % to 1 wt. % of the total weight of the personal care composition. Additional diluents can be included in the topically acceptable personal care composition to adjust the amount of the aqueous and/or non-aqueous liquid phases in the personal care composition. Water and/or the non-aqueous phase media discussed previously can be added to the personal care composition to bring these phases within the disclosed ranges. Neutralizers and pH adjusters can be included in the topically acceptable personal care composition to bring the pH of the personal care composition to desired levels. Suitable neutralizers and pH adjusters include, but are not limited to, triethanolamine, aminomethyl propanol, ammonium hydroxide, sodium hydroxide, other alkali hydroxides, borates, phosphates, pyrophosphates, cocamine, oleamine, diisopropanolamine, diisopropylamine, dodecylamine, PBG-15 cocamine, morpholine, tetrakis(hydroxypropyl)ethylenediamine, triamylamine, triethanolamine, triethylamine, tromethamine (2-Amino-2-Hydroxymethyl-1,3-propanediol, ascorbic acid and salts thereof, sorbic acid and salts thereof, phosphoric acid and salts thereof, citric acid and salts thereof, lactic acid and salts thereof, glycolic acid and salts thereof, boric acid and salts thereof, acetic acid and salts thereof, and the like, and mixtures thereof. In one aspect of the invention neutralizers or pH adjusters are utilized in the personal care composition of the invention in an amount sufficient to impart a pH ranging from 4 to 10. In another aspect the pH adjusters are utilized in an amount sufficient to impart a pH ranging from 4.5 to 8, and in a further aspect from 5 to 7.5. If desired, opacifiers can be included in the topically acceptable personal care composition. These include, but are not limited to, glycol fatty acid esters such as glycol dibehenate, glycol dioleate, glycol distearate, glycol ditallowate, glycol hydroxystearate, glycol montanate, glycol palmitate, and glycol stearate; fatty acids and hydrogenated fatty acid blends such as behenic acid, arachidic acid, palmitic acid, myristic acid, corn acid, palm acid, palm kernel acid, hydrogenated coconut acid, hydrogenated menhaden acid, hydrogenated palm acid, hydrogenated tallow acid, alkoxylated fatty acid esters; silica; alkanolamides such as behenamide, linoleamide, and stearamide; talc; nylon, fatty acid alcohols such as arachidyl alcohol, behenyl alcohol, stearyl alcohol, cetyl alcohol, and myristyl alcohol; waxes and oils; kaolin; magnesium silicate; titanium dioxide; and the like, and mixtures thereof. Opacifiers, if utilized, comprise from 0.1 wt. % to 8 wt. % of the total weight of the personal care composition. In another aspect the amount ranges from 0.5 wt. % to 6 wt. %, and in a further aspect from 1 wt. % to 5 wt. % of the total weight of the personal care compositions of the present invention. The preservatives that can be included in the topically acceptable personal care composition are, but are not limited to, polymethoxy bicyclic oxazolidine, methylparaben, propylparaben, ethylparaben, butylparaben, benzoic acid and the salts of benzoic acid, benzyltriazole, DMDM hydantoin (also known as 1,3-dimethyl-5,5-dimethyl hydantoin), imidazolidinyl urea, phenoxyethanol, phenoxyethylparaben, inethylisothiazolinone, methylchloroisothiazolinone, benzoisothiazolinone, triclosan, sorbic acid, salicylic acid salts, and the like, and mixtures thereof. In one aspect of the invention the preservative(s), if present, comprises 0.01 wt. % to 1.5 wt. % of the total weight of the personal care composition. In another aspect the amount of preservative ranges from 0.1 wt. % to 1 wt. %, and in a further aspect from 0.3 wt. % to 1 wt. % of the total weight of the personal care compositions of the present invention. The spreading aids that can be included in the topically acceptable personal care composition are, but are not limited to, hydroxypropyl methylcellulose, hydrophobically modified cellulosics, xanthan gum, cassia gum, guar gum, locust bean gum, dimethicone copolyols of various degrees of alkoxylation, boron nitride, talc, and the like, and mixtures thereof. In one aspect of the invention the spreading aid(s), if present, comprises 0.01 wt. % to about 5 wt. % of the total weight of the personal care composition. In another aspect the amount ranges from 0.1 wt. % to 3 wt. %, and in a further aspect from 0.1 wt. % to 2.0 wt. % of the total weight of the personal care compositions of the present invention. The rheology modifiers that_can be included in the topically acceptable personal care composition include synthetic polymers and natural thickeners. Exemplary synthetic polymers include, but are not limited to, carbomers, acrylates/C10-C30 alkyl acrylate crosspolymer, acrylates copolymer, polyacrylamide and C13-C14 isoparaffin and laureth-7 (supplied as SEPIGEL® 305 by SEPPIC), acrylamides copolymer and mineral oil and C13-C14 isoparaffin and polysorbate 85 (supplied as SEPIGEL® 501 by SEPPIC), C13-C14 isoparaffin and isostearyl isostearate and sodium polyacrylate and polyacrylamide and polysorbate 60 (supplied as SEPIGEL® 502 by SEPPIC), acrylamide/sodium acryloyldimethyltaurate copolymer and isohexadecane and polysorbate 60 (supplied as Simulgel® 600 by SEPPIC), sodium polyacryloyldimethyltaurate and isohexadecane and sorbitan oleate (supplied as Simulgel® 800 by SEPPIC), ammonium polyacrylate and isohexadecane and PEG-40 castor oil (supplied as Simulgel® A by SEPPIC), sodium acrylate/acryloyldimethyltaurate copolymer and isohexadecane and polysorbate 80 (supplied as Simulgel® EG by SEPPIC), sodium acrylate/acryloyldimethyltaurate copolymer and polyisobutene and caprylyl/capryl glucoside (supplied as Simulgel® EG-SL by SEPPIC), hydroxyethyl acrylate/sodium acryloyldimethyltaurate copolymer and squalane and polysorbate 60 (supplied as Simulgel® NS by SEPPIC), hydrophobically modified alkali swellable emulsion polymers (HASE). Natural thickeners include, but are not limited to, cellulosics and hydrophobically modified cellulosics, xanthan gum, guar gum, cassia gum, and aluminum magnesium silicate. In one aspect of the invention the rheology modifiers, if utilized, comprise from 0.01 wt. % to 5 wt. % of the total weight of the personal care composition. In another aspect the amount ranges from 0.1 wt. % to 3 wt. %, and in a further aspect from 0.1 wt. % to 2.0 wt. % of the total weight of the personal care compositions of the present invention. The viscosity adjusters that can be included in the topically acceptable personal care composition include isopropyl alcohol, ethanol, sorbitol, propylene glycol, diethylene glycol, triethylene glycol, dimethyl ether, butylene glycol, and the like, and mixtures thereof. The viscosity adjusters, if utilized, comprise from 0.1 wt. % to 60 wt. % of the total weight of the personal care composition. In another aspect the amount ranges from 1 wt. % to 40 wt. %, and in a further aspect from 5 wt. % to 20 wt. % of the total weight of the personal care compositions of the present invention. Other optional components can be used in order to maintain and enhance the properties of the personal care compositions of the present invention. Such optional components include various polymers for aiding the film-forming properties and substantivity of the compositions, antioxidants, and agents suitable for aesthetic purposes, such as fragrances, pigments, colorings, glitter, pearlizing agents, and the like. The inverse emulsion polymers described herein have better electrolyte stability and are more efficient than those of the prior art, i.e., less polymer is needed to provide compositions desired by the personal care industry. The improved personal care compositions of the present invention also are less sensitive to shear than those of the prior art, resulting in longer shelf and use life of the final personal care compositions, excellent formulation aesthetics (skin feel, residue, moisturizing, emolliency, rub-in, absorption and adsorption characteristics, and the like). It is to be noted that while varying ranges of the component ingredients of the present personal care composition have been disclosed, the amount of each component selected for the personal care composition will depend on the desired end-use and properties of the composition. In all instances the amount of each ingredient employed in the personal care composition will be selected from the disclosed range such that the summation of ingredient amounts total 100 wt. %. The following examples are presented for the purpose of illustrating various aspects of the invention disclosed herein in greater detail. The examples, however, are not to be construed as limiting the claimed invention herein in any manner. All ingredient amounts in the following examples are listed as weight percentages based on the total weight of the respective personal care composition. Polymer concentrations used in the following examples are an "as supplied" (polymer and carrier) weight percentage amount of polymer based on the total weight of the respective personal care composition unless specified as "weight percent based on polymer solids". In the case of weight percent based on polymer solids, this is defined as the amount of polymer added based on the total weight of monomer in the reaction mixture. Brookfield viscosity was measured using a Brookfield DVII+ viscometer with the appropriate RV spindle and speed indicated in each example below, viscosity readings were taken after the sample was subjected to three minutes of testing using the Brookfield DVII+ Viscometer (Brookfield Engineering Labs., Inc.). As is well-known by those of ordinary skill in the art, the selection of spindle size and speed to obtain an accurate viscosity reading is well-known (See "More Solutions to Sticky Problems", Brookfield Engineering Labs, Inc., p. 9, copyright, April 2000 and available on the Internet at http://www.brookfieldengineering.com/support/viscosity). Yield value was calculated using the formula (Va - Vb)/100, wherein Va is the viscosity at the slowest available viscometer speed, and Vb is the viscosity at the next-to-slowest viscometer speed. See "More Solutions to Sticky Problems", p. 21, Freeze/thaw (F/T) performance was tested by placing a sample in a freezer for 24 hours, removing the sample from the freezer and allowing it to thaw for 24 hours, and then repeating the freeze/thaw cycle four more times. A "pass" was regarded as no phase separation of the sample after five cycles as determined by visual inspection. The electrolyte tolerance of the inverse emulsion polymers utilized in the personal care compositions of the present invention is expressed in terms of viscosity maintained after a thickened sample of inverse emulsion polymer in water has been exposed to a known amount of salt. An initial sample is prepared by weighing an appropriate amount of polymer solids (based on neat polymer) and dispersing the polymer in deionized water to give a 1 wt. % w/w polymer dispersion in water. The dispersion is then mixed using a Heidolph High Torque Mixer (Fisher Scientific 2000/2001 Catalog No. 14-500) outfitted with a 3-bladed marine propeller mixing blade (5.08 cm (2 in.) diameter, Cole-Parmer Instrument Co. 2001/2002 Cat. No. U-04553-64) mounted on an 45.72 cm (18 in.) blade shaft (Cole-Parmer Instrument Co. 2001/2002 Cat. No. U-04553-55) at 800-1200 rpm for 20 minutes. At the completion of the mixing cycle, the initial viscosity of the sample is measured by placing the mixed sample on a Brookfield DVII+ Viscometer with a speed setting of 20 rpm and the appropriate RV spindle (No. 6 spindle). The initial viscosity reading is taken at 3 minutes into the measurement and recorded. Upon the determination of the initial viscosity, a quantity of monovalent salt (NaCl) or divalent salt (MgCl2) sufficient to give a salt concentration of 0.1 % or (depending on the test parameter utilized) w/w (based on the total weight of the initial sample) is added to the sample under hand stirring for 5 minutes. The salt containing sample placed on the Brookfield DVII+ Viscometer set at 20 rpm (no. 4 spindle). The final viscosity reading is taken 3 minutes into the measurement and recorded. Percent viscosity maintained is calculated using the following equation: All ingredients are listed in Table 1, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined by dissolving disodium EDTA (disodium ethylene diamine tetraacetic acid) in water, mixing until uniform, and heating the Part A mixture to 45°C. All four Part B ingredients were mixed in a separate vessel, and heated with mixing until the paraben compounds were dissolved. The Part B mixture was added with continuous mixing to the Part A mixture and heated with mixing to 65°C. Part C ingredients then were added to the mixture and mixed until the temperature fell to 40°C. Acrylic Acid Copolymer was added and mixing continued for two hours. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer with a marine propeller mixing blade. The hand and body lotion was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities and freeze/thaw (F/T) test results were obtained as set forth in Table 2. All ingredients are listed in Table 3, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined heating to 35°C. Part B ingredients were mixed in a separate vessel, and heated with mixing until cocoa butter was dissolved. The Part A mixture was added with continuous mixing to the Part B mixture. Part C ingredients then were added to the mixture and mixing was continued until the finished product was smooth and homogeneous. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer and a marine propeller mixing blade. The body lotion containing sodium PCA was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities and freeze/thaw (F/T) test results were obtained as set forth in Table 4. All ingredients are listed in Table 5, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined and with mixing and heated to 55°C. Part B ingredients were mixed in a separate vessel, and heated to 55°C. Part A was added to Part B with mixing at 55°C and mixed until homogeneous with heat removed. Part C ingredients were added at 40°C with mixing. Part D was added at room temperature with mixing. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer and a marine propeller mixing blade. The sprayable sunscreen was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities were obtained as set forth in Table 6. All ingredients are listed in Table 7, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined with mixing and heated to 65°C. Part B ingredients were mixed in a separate vessel without adding the zinc oxide material, and heated to 65° C. Part A was added to Part B with mixing at 65°C and mixed until homogeneous with heat removed. Zinc oxide was added to the composition with agitation at 65° C. Part C ingredients were added at 40° C with mixing. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer and a marine propeller mixing blade. The day cream with physical sunscreen was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities were obtained as set forth in Table 8. All ingredients are listed in Table 9, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined with mixing for 5 minutes at 1100 rpm. Part B is slowly added to Part A with rapid agitation. Part C ingredients were slowly added with mixing. Mixing was continued until homogeneous. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer and a marine propeller mixing blade. The sprayable after-sun moisturizer was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities were obtained as set forth in Table 10. All ingredients are listed in Table 11, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined with mixing and heated to 65°C. Part B ingredients were combined and heated to 65°C with mixing (polymer was added after reaching temperature of 65°C). Part A was added to Part B with rapid agitation. Part C ingredients were added in order when composition temperature was below 40°C. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer and a marine propeller mixing blade. The facial moisturizer was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities were obtained as set forth in Table 12. All ingredients are listed in Table 13, together with weight percentage, function, trade name (if available) and supplier (if available) of each ingredient. Part A ingredients were combined with mixing and heated to 70°C. Part B ingredients were combined and heated to 70°C with mixing (polymer was added after reaching temperature of 70°C). Part A was added to Part B with rapid agitation. Part C ingredients were added in order when composition temperature was below 40°C. All mixing was moderate, i.e., 800-1200 rpm using a Heidolph mixer and a marine propeller mixing blade. The night cream with moisturizing actives was tested as follows. All viscosities were measured after 3 minutes of stirring using a #6 spindle at 20 rpm. Viscosities were obtained as set forth in Table 14. Example 8 demonstrates the superior thickening ability of the inverse emulsion polymer used in the personal care compositions of the present invention, as compared to two commercially available thickeners. Samples were prepared by mixing the indicated weight percentages based on polymer solids into deionized water and allowing to mix for 20 minutes at 800-1200 rpm using a Heidolph mixer with a marine propeller blade and thereafter measuring viscosities using # 3 to #6 spindles at 20 rpm. Test data is set forth in Table 15. Example 9 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention provides superior yield values, as compared to two commercially available thickeners. Samples were prepared by mixing the indicated weight percentages based on polymer solids into deionized water and allowing to mix for 20 minutes at 800-1200 rpm using a Heidolph mixer with a marine propeller blade and thereafter measuring viscosities using #3 to #6 spindles at 1.0 rpm and at 0.5 rpm, and using the following equation. Test data is set forth in Table 16. Example 10 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention provides superior electrolyte tolerance (indicated by higher viscosity), as compared to two commercially available thickeners. Polymer samples were prepared by adding them at a concentration of 1.0 wt. % based on polymer solids into deionized water. The sample was mixed using a Heidolph mixer and a marine propeller mixing blade. Mixing was done at 800-1200 rpm for 20 minutes. Sample viscosities were then measured using a Brookfield DVII+ Viscometer set at a speed of 20 rpm using RV spindles. Viscosities were recorded at three (3) minutes into the measurement. Once viscosities were measured, known quantities of monovalent salt, in this case sodium chloride, or in the case of divalent salt, magnesium chloride was added to the sample with hand mixing for 5 minutes. After each addition of salt, a viscosity reading was taken and listed in the following table, and thereafter measuring viscosities using Brookfield #2 to 6 spindles at 20 rpm. Test data is set forth in Table 17. Example 11 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention provides superior electrolyte tolerance (indicated by higher viscosity), as compared to commercially available thickeners. Polymer samples were prepared by mixing them at a concentration of 2.0 wt. % based on polymer solids into deionized water. The sample was mixed using a Heidolph mixer and a marine propeller mixing blade. Mixing was done at 800-1200 rpm for 20 minutes. Sample viscosities were then measured using a Brookfield DVII+ Viscometer set at a speed of 20 rpm using RV spindles. Viscosities were recorded at three (3) minutes into the measurement. Once viscosities were measured, known quantities of monovalent salt, in this case sodium chloride, or in the case of divalent salt, magnesium chloride was added to the sample with hand mixing for 5 minutes. After each addition of salt, a viscosity reading was taken and recorded as listed in the following table, and thereafter measuring viscosities using Brookfield #2 to 6 spindles at 20 rpm. Test data is set forth in Table 19. Example 12 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention provides superior yield values in the presence of electrolyte, as compared to commercially available thickeners. Samples were prepared by mixing them at the indicated weight percentages into deionized water and thereafter measuring viscosities using #3 to 6 spindles at 1.0 rpm and at 0.5 rpm, and using the following equation. Test data is set forth in Table 20. Example 13 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention provides superior electrolyte tolerance (indicated by higher viscosity), as compared to two commercially available thickeners. Polymer samples were prepared by mixing them at a concentration of 1.0 wt. % based on polymer solids into deionized water. The sample was mixed using a Heidolph mixer and a marine propeller mixing blade. Mixing was done at 800-1200 rpm for 20 minutes. Sample viscosities were then measured using a Brookfield DVII+ Viscometer set at a speed of 20 rpm using RV spindles. Viscosities were recorded at three (3) minutes into the measurement. Once viscosities were measured, known quantities of divalent salt, magnesium chloride, was added to the sample with hand mixing for 5 minutes. After each addition of salt, a viscosity reading was taken and recorded in the following table, and thereafter measuring viscosities using Brookfield #2 to 6 spindles at 20 rpm. Test data is set forth in Table 21. Example 14 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention is capable of emulsifying various oils and commonly used non-aqueous ingredients. Samples were prepared by adding 1.0 wt. % based on polymer solids to either the oil phase or the water phase prior to phasing the two phases together, mixing was done at 800-1200 rpm for 20 minutes using a Heidolph mixer with a marine propeller mixing blade. Formulations are listed in Table 22. Overall emulsion stabilities were evaluated at 45° C for 12 weeks and viscosities were measured using Brookfield #2 to 6 spindles at 20 rpm. Test data is set forth in Table 23. Stability data of the emulsions made in Table 22 are found in Table 23. Viscosity measurements were taken on samples for 12 weeks at 45°C. Viscosity was measured using a Brookfield Viscometer DVII++. Measurements were taken at 20 rpm using RV spindles, units are mPa·s. All emulsions in Table 22 appeared homogeneous without separation over the 12 week stability study at 45°C. Example 15 demonstrates that the inverse emulsion polymer used in the personal care compositions of the present invention is capable of emulsifying various oils and commonly used non-aqueous ingredients. Samples were prepared by adding approximately 0.5 wt. % by weight polymer solids to either the oil phase or the water phase, prior to phasing the two phases together, or to the phased emulsion. All mixing was done using a Heidolph mixer and a marine propeller mixing blade for 20 minutes at 800-1200 rpm. Formulations are listed in Table 24. Micrograms of the emulsions are shown in Figs. 1 to 3. Referring to Fig. I, the polymer was added to the water phase prior to emulsification (Formulation P-A). The oil phase was added to the water/polymer phase with rapid agitation. The particle size of the oil droplets is uniform and approximately 10-15 µm. Microscopy completed using an Olympus BH-2 Microscope at 200X magnification. Olympus PM-10AK Camera. In Fig. 2, the polymer was added to the oil phase prior to emulsification (Formulation P-B). The water phase was added to the oil/polymer phase with rapid agitation. The particle size of the oil droplets is uniform and approximately 10 - 15 µm. Microscopy completed using an Olympus BH-2 Microscope at 200X magnification. Olympus PM-10AK Camera. In Fig. 3, the oil phase was added to the water phase with rapid agitation. The polymer was then added to the combined phases with rapid agitation (Formulation P-C). The particle size of the oil droplets is uniform and approximately 7-12.5 µm. Microscopy completed using an Olympus BH-2 Microscope at 200X magnification. Olympus PM-10AK Camera. The foregoing experiments demonstrate that the salt tolerant inverse emulsion polymers of the present invention can be formulated under a wide variety of conditions forming stable emulsions. The order of addition of the inverse emulsion polymer of this invention in the formation of a multiphase emulsified system does not deleteriously affect the stability and emulsifying properties of the polymer. As is illustrated in Figs. 1 to 3, stable emulsions with uniform droplet sizes are obtained regardless of the phase in which the polymer is initially dispersed. These polymer attributes offer the formulator ease and versatility in the processing and manufacture of personal care compositions. Personal care compositions having excellent shear, shelf and use stability as well as excellent formulation aesthetics (such as skin feel, residue, moisturizing, emolliency, rub-in, absorption and adsorption characteristics, and the like) are made using inverse emulsion polymers having improved electrolyte tolerance and efficiency. The personal care compositions comprise (A) a topically acceptable liquid phase, and (B) at least one electrolyte tolerant inverse emulsion polymer comprising the reaction product of: (1) at least one complex associative monomer having ethylenic unsaturation in an end group, a hydrophilic midsection, and a hydrophobic moiety; (2) at least one pH sensitive monomer having ethylenic unsaturation and at least one carboxylic or sulfonic acid group; (3) an optional copolymerizable non-ionic monomer having ethylenic unsaturation; and (4) at least one crosslinking monomer. A personal care emulsion composition for topical application to the skin comprising: a) a continuous aqueous liquid phase; b) a non-aqueous phase; c) an electrolyte tolerant inverse emulsion polymer composition comprising: i) a polymer polymerized from a monomer composition comprising (1) at least one pH sensitive monomer having ethylenic unsaturation and containing at least one carboxylic acid moiety, wherein at least 50 wt. % of said monomers containing said carboxylic acid moiety are neutralized; (2) a complex associative monomer represented by the structure: wherein A is selected from a divalent radical represented by -C(O)O-, -CH2C(O)O-, -O-, -CH2O-, NHC(O)O-, -(CH2)mNHC(O)-, -NHC(O)NH-, -C(O)NH-, -C(O)NH(CH2)m-, B is selected from a divalent radical represented by -CH2CH2O-, -CH2CH(CH3)O-, -CH2CH2CH2O-, -C(O)-, -(CH2)mNHC(O)-, and -(CH2)mNHC(O)NH-, wherein m represents an integer from 0 to 18; R1 is selected from H, -CH3 and -COOH; R2 is selected from H, -CH3 and - COOH; R3 is selected from -CH2CH2O-, -CH2CH(CH3)O-, -CH2CH2CH2O- and mixtures thereof wherein n is an integer from 1 to about 250; and R4 is selected from substituted and unsubstituted linear and branched C8-C30 alkyl, substituted and unsubstituted C8-C40 alicyclic, C8-C30 alkylaryl wherein the aryl moiety contains 6 to 17 carbon atoms, C6-C17 arylalkyl wherein the alkyl moiety contains 8 to 30 carbon atoms, substituted and unsubstituted C5-C40 carbocylic groups; and (3) a crosslinking monomer; said complex associative monomer is present in the monomer composition in a weight ranging from 0.0001 wt. % to 3 wt. % based on the total weight of monomers present in the composition; and ii) at least one surfactant having an HLB value less than 7; wherein said polymer maintains at least 50 % of its original Brookfield Viscosity value when 0.1 wt. % of sodium chloride is added to 1 wt. % polymer solids in deionized water (w/w); d) at least one adjuvant; and e) a high HLB emulsifier having an HLB value of 7.5 or greater in an amount sufficient to allow said polymer in component to associate with said aqueous phase. The composition of claim 1 wherein said monomer composition further contains a pH sensitive monomer selected from a monomer having ethylenic unsaturation and a sulfonic acid moiety, a monomer having ethylenic unsaturation and a neutralized sulfonic acid moiety, and mixtures thereof. The composition of claim 1 wherein said monomer composition further contains a copolymerizable non-ionic monomer selected from C2-C6 hydroxy alkyl acrylates and methacrylates, glycerol monomethacrylate, tris(hydroxymethyl) ethane monoacrylate, pentaerythritol monomethacrylate, N-hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, acrylamide, hydroxypropyl methacrylamide, vinyl caprolactam, N-vinyl pyrrolidone, C1-C4 alkoxy substituted methacrylates and methacrylamides, polyethylene glycol mono methacrylate and polypropylene glycol mono methacrylate, and mixtures thereof. The composition of claim 1 wherein said complex associative monomer is selected from lauryl polyethoxylated methacrylate, palmityl polyethoxylated methacrylate, cetyl polyethoxylated methacrylate, cetylstearyl polyethoxylated methacrylate, stearyl polyethoxylated methacrylate, tristearylphenol polyethoxylated methacrylate, arachidyl polyethoxylated methacrylate, behenyl polyethoxylated methacrylate, cerotyl polyethoxylated methacrylate, montanyl polyethoxylated methacrylate, melissyl polyethoxylated methacrylate, lacceryl polyethoxylated methacrylate, and mixtures thereof. The composition of claim 1 wherein said pH sensitive monomer is selected from acrylic acid, methacrylic acid, itaconic acid, citraconic acid, maleic acid, fumaric acid, crotonic acid, C1-C4 alkyl half esters of maleic, fumaric, itaconic acid, aconitic acid, and mixtures thereof. The composition of claim 5 wherein 65 wt. % to 100 wt. % of the carboxylic acid groups on said pH sensitive monomer are neutralized. The composition of claim 6 wherein said neutralized pH sensitive monomer is selected from the lithium, sodium, potassium, ammonium and amine salt of acrylic acid, methacrylic acid, itaconic acid, citraconic acid, maleic acid, fumaric acid, crotonic acid, C1-C4 alkyl half esters of maleic, fumaric, itaconic acid, aconitic acid, and mixtures thereof. The composition of claim 2 wherein said monomer contains the lithium, sodium, potassium, ammonium and amine salt of said sulfonic acid. The composition of claim 1 wherein said adjuvant is selected from humectants, emollients, biologically active materials, botanical extracts, conditioners, sunscreens, pharmaceutical actives, conditioning polymers, vitamins, cleansing surfactants, and mixtures thereof. The composition of claim 1 wherein said high HLB surfactant is selected from high HLB C8-C22 alcohol ethoxylates, ethoxylated vegetable derived oils, ethoxylated C8-C22 fatty acids, C8-C9 alkyl phenol ethoxylates, esters of sorbitol, ethoxylated esters of sorbitol, and mixtures thereof The composition of claim 1 wherein said crosslinking monomer contains at least two terminal CH2=CH- groups. The composition of claim 11 wherein said crosslinking monomer is selected from allyl pentaerythritol, methylene bis acrylamide, allyl sucrose, trimethylolpropane triacrylate, trimethylolpropane trimethacrylate, 1,6-hexanediol diacrylate, trimethylolpropane diallyl ether, pentaerythritol triacrylate, tetramethylene dimethacrylate, ethylene diacrylate, ethylene dimethacrylate, triethylene glycol dimethacrylate, and mixtures thereof. The composition of claim 1 wherein said crosslinking monomer is present in an amount ranging from 0.0001 wt. % to 2 wt. % based on the total weight of monomers present in said monomer composition. The composition of claim 3 wherein said non-ionic monomer is present in a range from about 1 to about 74.9998 based on the total weight of monomers present in said monomer composition. The composition of claim 14 wherein said pH sensitive monomer mixture is present in the monomer composition in an amount ranging from about 25 wt. % to about 99.9998 wt. % based on the total weight of monomers present in said monomer composition. The composition of claim 1, 2, 6 or 15 wherein said salt containing monomer is present in said pH sensitive monomer mixture in a range from 40 wt. % to 95 wt. % based on the total weight of said pH sensitive monomer mixture. The composition of claim 1 or 9 wherein said composition further comprises a formulation aid selected from chelating agents, pH adjusters, opacifiers, preservatives, spreading agents, viscosity adjusters, rheology modifiers, film forming polymers, antioxidants, fragrances, colorants, pigments, glitter, pearlizing agents, and mixtures thereof. The composition of claim 1 or 3 wherein said associative monomer is present in an amount ranging from 0.001 wt. % to 0.9 wt. % based on the total weight of monomers present in said monomer composition. The composition of claim 1 wherein said polymer (i) is present in an amount ranging from 0.01 wt. % to 10 wt. % of the total weight of the personal care composition and is polymerized from a monomer composition comprising (1) from 25 wt. % to 99.9998 wt. % of said at least one pH sensitive monomer having ethylenic unsaturation and containing at least one carboxylic acid moiety, wherein at least 65 wt. % of said monomers containing said carboxylic acid moiety are neutralized; (2) from 0.0001 wt. % to 0.9 wt. % of said complex associative monomer; and (3) from 0.0001 wt. % to 2 wt. % of said crosslinking monomer; wherein said wt. % ranges are based on the total weight of monomers present in said monomer composition. The composition of claim 1 or 10 wherein said high HLB surfactant is present in an amount ranging from about 0.2 wt. % to about 10 wt. % based on the total wt. of the monomers in said monomer composition. The composition according to claim 19 further comprising: at least one adjuvant selected from humectants, emollients, biologically active materials, botanical extracts, conditioners, sunscreens, pharmaceutical actives, conditioning polymers, vitamins, cleansing surfactants, and mixtures thereof.; and a formulation aid selected from chelating agents, pH adjusters, opacifiers, preservatives, spreading agents, viscosity adjusters, rheology modifiers, film forming polymers, antioxidants, fragrances, colorants, pigments, glitter, pearlizing agents, and mixtures thereof. The composition of claim 21 wherein said monomer composition comprises from 1 wt. % to 74.9998 wt. % of a non-ionic monomer selected from C2-C6 hydroxy alkyl acrylates and methacrylates, glycerol monomethacrylate, tris(hydroxymethyl) ethane monoacrylate, pentaerythritol monomethacrylate, N-hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, acrylamide, hydroxypropyl methacrylamide, vinyl caprolactam, N-vinyl pyrrolidone, C1-C4 alkoxy substituted methacrylates and methacrylamides, polyethylene glycol mono methacrylate and polypropylene glycol mono methacrylate, and mixtures thereof. The composition of claim 21 wherein said pH sensitive monomer is selected from acrylic acid and salts thereof, methacrylic acid and salts thereof, itaconic acid and salts thereof, citraconic acid and salts thereof, maleic acid and salts thereof, fumaric acid and salts thereof, crotonic acid and salts thereof, C1-C4 alkyl half esters of maleic, fumaric, itaconic acid, aconitic acid, and salts thereof; and mixtures thereof. The composition of claim 21 wherein said wherein said monomer composition further contains a monomer selected from a monomer having ethylenic unsaturation and a sulfonic acid moiety, a monomer having ethylenic unsaturation and a salt of a sulfonic acid moiety, and mixtures thereof. The composition of claim 21 wherein said pH sensitive monomer is selected from 2-acrylamido-2-methylpropane sulfonic acid, sodium p-styrene sulfonate, sulphoethyl methacrylate, and salts thereof; and mixtures thereof. The composition of claim 24 wherein said pH sensitive monomer selected from sulfonic acid containing monomers, salts thereof, and mixtures thereof is present in said monomer composition in an amount ranging from 1 wt. % to 30 wt. % of the total pH sensitive monomer in said monomer composition. The composition of claim 21 wherein said complex associative monomer is selected from lauryl polyethoxylated methacrylate, palmityl polyethoxylated methacrylate, cetyl polyethoxylated methacrylate, cetylstearyl polyethoxylated methacrylate, stearyl polyethoxylated methacrylate, tristearylphenol polyethoxylated methacrylate, arachidyl polyethoxylated methacrylate, behenyl polyethoxylated methacrylate, cerotyl polyethoxylated methacrylate, montanyl polyethoxylated methacrylate, melissyl polyethoxylated methacrylate, lacceryl polyethoxylated methacrylate, and mixtures thereof. The composition of claim 27 wherein said complex associative monomer contains from about 10 to about 30 ethylene oxide units. The composition of claim 21 wherein said crosslinking monomer is selected from allyl pentaerythritol, methylene bis acrylamide, allyl sucrose, trimethylolpropane triacrylate, trimethylolpropane trimethacrylate, 1,6-hexanediol diacrylate, trimethylolpropane diallyl ether, pentaerythritol triacrylate, tetramethylene dimethacrylate, ethylene diacrylate, ethylene dimethacrylate, triethylene glycol dimethacrylate, and mixtures thereof. The composition of claim 21 wherein said non-aqueous phase is selected plant and vegetable oils, silicone oils, fluorinated hydrocarbon oils, hydrocarbon oils, mineral oils, polyisobutene, isohexadecane, caprylic/capric triglycerides, cetearyl octanoate, C12-C14 alkyl benzoate, and mixtures thereof. The composition according to claim 1 comprising: a) from 0.01 wt. % to 10 wt. % of said inverse emulsion polymer composition based on the total weight of the personal care composition; b) at least one adjuvant selected from humectants, emollients, biologically active materials, botanical extracts, conditioners, sunscreens, pharmaceutical actives, conditioning polymers, vitamins, cleansing surfactants, and mixtures thereof; c) a formulation aid selected from chelating agents, pH adjusters, opacifiers, preservatives, spreading agents, viscosity adjusters, rheology modifiers, film forming polymers, antioxidants, fragrances, colorants, pigments, glitter, pearlizing agents, and mixtures thereof; and d) from 0.2 wt. % to 10 wt. % based on the total wt. of monomers in said monomer composition of a high HLB emulsifier having an HLB value of 7.5 or greater, wherein said inverse emulsion polymer composition comprises: i) a polymer polymerized from a monomer composition comprising (1) from 25 wt. % to 99.9998 wt. % at least one pH sensitive monomer selected from acrylic acid and salts thereof, methacrylic acid and salts thereof, itaconic acid and salts thereof, citraconic acid and salts thereof, maleic acid and salts thereof, fumaric acid and salts thereof, crotonic acid and salts thereof, C1-C4 alkyl half esters of maleic, fumaric, itaconic acid, aconitic acid, and salts thereof; and mixtures thereof, where at least 65 wt. % of said monomers are neutralized; (2) from 0.001 wt. % to 0.75 wt. % of a complex associative monomer selected from lauryl polyethoxylated methacrylate, palmityl polyethoxylated methacrylate, cetyl polyethoxylated methacrylate, cetylstearyl polyethoxylated methacrylate, stearyl polyethoxylated methacrylate, tristearylphenol polyethoxylated methacrylate, arachidyl polyethoxylated methacrylate, behenyl polyethoxylated methacrylate, cerotyl polyethoxylated methacrylate, montanyl polyethoxylated methacrylate, melissyl polyethoxylated methacrylate, lacceryl polyethoxylated methacrylate, and mixtures thereof, wherein said polyethoxylated moiety contains from 10 to 30 ethylene oxide repeating units; (3) from 1 wt. % to 74.9998 wt. % of a non-ionic monomer selected from C2-C6 hydroxy alkyl acrylates and methacrylates, glycerol monomethacrylate, tris(hydroxymethyl) ethane monoacrylate, pentaerythritol monomethacrylate, N-hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, acrylamide, hydroxypropyl methacrylamide, vinyl caprolactam, N-vinyl pyrrolidone, C1-C4 alkoxy substituted methacrylates and methacrylamides, polyethylene glycol mono methacrylate and polypropylene glycol mono methacrylate, and mixtures thereof; and (4) from 0.0001 wt. % to 2 wt. % based on the total weight of monomers present in the monomer composition of a crosslinking monomer; wherein said wt. % ranges are based on the total weight of monomers present in said monomer composition; and ii) at least one surfactant having an HLB value less than 7; wherein said polymer maintains at least 25 % of its original Brookfield Viscosity value when 0.25 wt. % of sodium chloride is added to 1 wt. % polymer solids in deionized water (w/w). The composition of claim 31 wherein said pH sensitive monomer is selected from acrylic acid and salts thereof, methacrylic acid and salts thereof, and mixtures thereof wherein from about 75 wt. % to about 95 wt. % of said monomers are neutralized. The composition of claim 32 wherein said non-ionic monomer selected from N-hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, acrylamide, hydroxypropyl methacrylamide, and mixtures thereof. The composition of claim 31 wherein said crosslinking monomer is selected from alkyl pentaerythritol, methylene bis acrylamide, allyl sucrose, trimethylolpropane triacrylate, trimethylolpropane trimethacrylate, 1,6-hexanediol diacrylate, trimethylolpropane diallyl ether, pentaerythritol triacrylate, tetramethylene dimethacrylate, ethylene diacrylate, ethylene dimethacrylate, triethylene glycol dimethacrylate, and mixtures thereof. The composition of claim 31 wherein said oil phase is a compound selected from mineral oil, vegetable oil, silicone oils, fluorinated hydrocarbon oils, hydrocarbon oils, and mixtures thereof. The composition of claim 31 wherein said high HLB surfactant is selected from high HLB C8-C22 alcohol ethoxylates, ethoxylated vegetable derived oils, ethoxylated C8-C22 fatty acids, C8-C9 alkyl phenol ethoxylates, esters of sorbitol, ethoxylated esters of sorbitol, and mixtures thereof.FIELD OF THE INVENTION
BACKGROUND OF THE INVENTION
SUMMARY OF THE INVENTION
BRIEF DESCRIPTION OF THE DRAWINGS
DETAILED DESCRIPTION OF THE INVENTION
Associative Monomer
pH Sensitive Monomer
Non-Ionic Monomer
Crosslinking Monomer
Preparation of Inverse Emulsion Polymer
Preparation of water phase
Preparation of oil phase
Preparation of water-in-oil emulsion
Polymerization
Topically Acceptable Composition
Liquid Phases
High HLB Surfactant
Personal Care Adjuvants
Humectants
Emollients
Pharmaceutical Actives
Botanical Extracts
Sunscreens
Cleansing Surfactants
Skin Conditioning Polymers
Vitamins
Formulation Aids
Chelating agents
Diluent
Neutralizers and pH Adjusters
Opacifiers
Preservatives
Spreading Aids
Rheology Modifiers
Viscosity Adjusters
EXAMPLES
Ingredient Amounts
Test Methods
Viscosity
Freeze/Thaw Determination
Measurement of Electrolyte or Salt Tolerance
Example 1 - Preparation of Hand and Body Lotion
Part A Deionized Water 83.75 Diluent Disodium EDTA 0.10 Chelation (Dow Chemical) Part B Propylene Glycol 0.80 Humectant Glycerin 5.00 Humectant Methylparaben 0.10 Preservative Propylparaben 0.10 Preservative Part C Mineral Oil 4.00 Moisture Barrier Drakeol™ 21 (Penreco) Stearic Acid 2.00 Moisture Barrier Hystren® 5016 NF 3X Pressed Glycol Stearate 1.50 Opacifier Cetyl Acetate/ Acetylated Lanolin Alcohol 0.50 Moisture Barrier Acetulan® (Amerchol) Glyceryl Stearate 0.50 Emulsifier Cetyl Alcohol 0.20 Moisture Barrier Dimethicone 0.50 Lubricant Dow Corning® 200 fluid, 100 cs. (Dow Corning) Acrylates / Acrylamide / C12-30 polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 1.13* Rheology modifier / Stabilizer *Novemer™ EC-1 polymer Initial 13,000 13,000 2 Weeks 12,720 12,400 4 Weeks 12,020 12,120 6 Weeks 12,500 11,760 8 Weeks 12,560 11,460 10 Weeks 12,460 11,020 12 Weeks 12,280 10,960 Formulation pH: 6.65 5 Cycle Freeze/ Thaw: Pass Example 2 - Preparation of Body Lotion Containing Sodium PCA
Part A Deionized Water 83.10 Diluent Glycerin 2.00 Humectant Part B Caprylic / Capric Triglycerides 5.00 Emollient Liponate® GC (Lipo) Sunflower Seed Oil 3.00 Emollient Lipovol® Sun (Lipo) Cetearyl Octanoate 2.00 Emollient Crodamol® CAP Cocoa Butter 1.50 Emollient Fancol™ CB USP (Fanning Corporation) Acrylates / Acrylamide / C12-30 polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 2.30* Emulsifer / Rheology modifier *Novemer™ EC-1 polymer Part C Fragrance 0.20 Fragrance Lotion Fragrance #7960 (Belle Aire Fragrances) DMDM Hydantoin 0.40 Preservative Glydant® (Lonza) Sodium Pyrrolidone Carboxylic Acid (50%) 0.50 Humectant Ajidew® N-50 (Ajinomoto) Initial 13,180 13,180 2 Weeks 14,020 12,300 4 Weeks 14,160 11,900 6 Weeks 14,100 12,040 8 Weeks 14,320 11,500 10 Weeks 14,160 11,460 12 Weeks 14,220 11,280 Formulation pH: 6.68 5 Cycle Freeze / Thaw: Pass Example 3 - Preparation of Sprayable Sunscreen
Part A Deionized water 71.15 Diluent Propylene Glycol 3.00 Humectant Part B Octyl Methoxycinnamate 7.00 UV-B Sunscreen Heliopan® AV (H&R) Octyl Salicylate 3.00 UV-B Sunscreen Octyl Salicylate (Noveon, Inc.) Avobenzone 2.50 UV-A Sunscreen Parsol® 1789 (Roche) PPG-2 Myristyl Ether Propionate 7.00 Emollient Crodamol® PMP (Croda) Octyl Stearate 2.50 Emollient Lexol® EHS (Inolex) Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 0.75* Emulsifier / Stabilizer / Rheology Modifier *Novemer™ EC-1 polymer (Noveon, Inc.) Part C PEG-20 Almond Glycerides 0.50 Emulsifier Crovol® A-40 (Croda) Cyclomethicone and Dimethiconol 2.00 Spread aid Dow Corning® DC 1401 (Dow Coming) Fragrance 0.25 Fragrance Twister 829 718 (Drom) DMDM Hydantoin 0.30 Preservative Glydant® (Lonza) Part D Disodium EDTA 0.05 Chelating agent Versene® Na2EDTA (Dow) Initial 3,385 3,385 2 Weeks 3,595 4,365 4 Weeks 3,830 4,390 6 Weeks 3,880 4,500 8 Weeks 4,020 4,500 10 Weeks 3,920 4,580 12 Weeks 4,000 4,580 Formulation pH: 6.70 5 Cycle Freeze / Thaw: Pass Example 4 - Day Cream with Physical Sunscreen
Part A Deionized water 72.85 Diluent Glycerin 8.00 Humectant Acrylates / Acrylamide / C12- 30polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 1.65* Rheology modifier / Stabilizer *Novemer™ EC-1 polymer (Noveon, Inc.) Disodium EDTA 0.05 Chelating Agent Versene® Na2EDTA (Dow) Part B Octyl Methoxycinnamate 5.00 UV-B Sunscreen Heliopan® AV (H&R) Isohexadecane 3.00 Emollient Arlamol® HD (Uniqema) Isopropyl Palmitate 1.50 Emollient Estol® 1517 (Uniqema) Dimethicone and Dimethiconol 1.00 Slip aid Dow Corning® DC 1403 Fluid (Dow Coming) Steareth-21 0.35 Emulsifier Brij 721 (Uniqema) Steareth-2 0.65 Emulsifier Brij 72 (Uniqema) Cetearyl Alcohol 1.00 Opacifier Lanette Wax® O (Cognis) Behenyl Alcohol 0.75 Opacifier Lanette® 22 (Cognis) DEA Oleth-3 Phosphate 0.50 Emulsifier Crodafos™ N-3 Neutral (Croda) Zinc Oxide and Dimethicone 3.00 UV-A block Z-Cote™ HP1 (BASF) Part C DMDM Hydantoin 0.50 Preservative Glydant® (Lonza) Vitamin E Acetate 0.20 Active Vitamin E Acetate (BASF) * Novemer™ EC-1 polymer used as commercially supplied, in the formulation Initial 27,000 27,000 2 Weeks 4 Weeks 29,400 23,200 6 Weeks 29,000 21,400 8 Weeks 28,400 17,500 10 Weeks 28,500 13,000 12 Weeks 29,000 13,000 Formulation pH: 8.70 5 Cycle Freeze / Thaw: Pass Example 5 - Sprayable After-Sun Moisturizer
Part A Deionized Water 85.15 Diluent Propylene Glycol and Diazolidinyl Urea and Methylparaben and Propylparaben 0.80 Preservative Germaben II™ (Sutton) Cetearyl Ethylhexanoate 1.50 Emollient Crodamol® CAP (Croda) Isopropyl Palmitate 3.00 Emollient Estol® 1517 (Uniqema) Safflower Seed Oil 4.00 Emollient Lipovol® SAF (Lipo) Cyclomethicone and Dimethiconol 0.50 Slip aid Dow Corning® DC 1401 Fluid (Dow Corning) PEG-7 Dimethicone Isostearate 0.85 Emulsifier Ultrasil™ DW-18 (Noveon, Inc.) Part B Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 2.00* Emulsifier / Rheology modifier *Novemer™ EC-1 polymer (Noveon, Inc.) Part C Aloe Barbadensis Leaf Juice 1.50 Botanical Active Aloe Vera Gel Concentrate 40:1 (Aloe Corp) Water and Hydrolyzed Coralina Officinalis (Coral Seaweed) 0.50 Humectant Oligophycocorail (Secma) Fragrance 0.20 Fragrance Dewfruit Bouquet J-7418-B (Bell Flavors and Fragrances Inc.) Initial 2,280 2,280 2 Weeks 2,195 2,255 4 Weeks 2,225 2,340 6 Weeks 2,295 2,420 8 Weeks 2,280 2,370 10 Weeks 2,260 2,310 12 Weeks 2,300 2,185 Formulation pH: 6.35 3 Cycle Freeze / Thaw: Pass Example 6 - Facial Moisturizer
Part A Deionized Water 83.60 Diluent Guar Hydroxypropyl-trimonium chloride 0.10 Skin conditioner Hi-Care® 1000 (Rhodia) Glycerin 3.00 Humectant Part B Octyl Stearate 3.00 Emollient Lexol® EHS (Inolex) Triticum Vulgare (Wheat) Germ Oil 2.00 Emollient Cropure® Wheatgerm (Croda) Cetyl Alcohol 1.00 Opacifier Lanette® 16 NF (Cognis) Octyl 2.00 UV-B Heliopan® AV Methoxycinnamate Sunscreen (H&R) Glyceryl Stearate and PEG-100 Stearate 1.50 Emulsifier Aralacel® 165 (Uniqema) Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 1.50* Emulsifier / Rheology modifier *Novemer™ EC-1 polymer (Noveon, Inc.) Part C Propylene Glycol and Cucumis Sativus (Cucumber) Fruit Extract 1.00 Botanical Active Vegetol® Cp GR 049 Hydro (Gattefosse) Propylene Glycol and Fucus Vesiculosus (Seaweed) Extract 1.00 Botanical Active Vegetol® Algues CB 4136 Hydro (Gattefosse) Phenoxyethanol and Methylparaben and Butylparaben and Ethylparaben and Propylparaben 0.30 Preservative Phenonip® (Clariant) Initial 33,100 33,100 2 Weeks 35,900 29,700 4 Weeks 35,750 29,000 6 Weeks N/A 28,000 8 Weeks N/A 24,000 10 Weeks N/A 24,250 12 Weeks N/A 24,000 Formulation pH: 6.84 5 Cycle Freeze / Thaw: Pass Example 7 - Night Cream with Moisturizing Actives
Part A Deionized Water 76.95 Diluent Glycerin 3.00 Humectant Part B Hydrogenated Polyisobutene 5.00 Emollient Panalane® L-14E (Lipo) Caprylic / Capric Triglycerides 3.50 Emollient Liponate® GC (Lipo) Isohexadecane 3.00 Emollient Arlamol® HD (Uniqema)) Evening Primrose Oil 2.00 Emollient Evening Primrose Oil (Croda) Glyceryl Stearate and PEG-100 Stearate 2.00 Emulsifier Aralacel® 165 (Uniqema) Cetearyl Alcohol / Ceteareth-20 1.20 Opacifier Emulgade® 1000NI (Cognis) Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 1.55* Emulsifier / Rheology modifier *Novemer™ EC-1 polymer (Noveon, Inc.) Part C Hydrolyzed Ellastin 1.00 Active Crolastin® (Croda) Hydrolyzed Protein / Hyaluronic Acid 0.50 Active Cromoist® HYA (Croda) Phenoxyethanol and Methylparaben and Butylparaben and Ethylparaben and Propylparaben 0.30 Preservative Phenonip® (Clariant) Initial 30,750 30,750 2 Weeks 28,400 29,100 4 Weeks 32,000 26,450 6 Weeks 33,000 26,750 8 Weeks 33,600 23,100 10 Weeks 33,100 23,200 12 Weeks 30,100 23,100 Formulation pH: 6.60 5 Cycle Freeze / Thaw: Pass Example 8 - Comparative Thickening Performance
Sepigel® 3051 1,400 (mPa·sec) 11,120 (mPa·sec) 20,350 (mPa·sec) 26,200 (mPa·sec) 30,900 (mPa·sec) Salcare® SC 912 1,475 (mPa·sec) 6,800 (mPa·sec) 12,700 (mPa·sec) 20,750 (mPa·sec) 27,350 (mPa·sec) Novemer ™ EC-1 polymer3 7,100 (mPa·sec) 15,600 (mPa·sec) 22,400 (mPa·sec) 26,200 (mPa·sec) 32,400 (mPa·sec) 1 2 3 Example 9 - Comparative Yield Values
Sepigel® 3051 64 850 1,492 2,216 2,300 Salcare® SC912 21 218 572 1,160 1,480 Novemer™ EC-1 polymer3 388 1,340 1,920 2,270 2,670 1 2 3 Example 10 - Monovalent Electrolyte Tolerance
Sepigel® 3051 28,100 (mPa·sec) 4,140 (mPa·sec) 550 (mPa·sec) 195 (mPa·sec) 42 (mPa·sec) 30 (mPa·sec) Salcare® SC912 20,750 (mPa·sec) 7,340 (mPa·sec) 1,685 (mPa·sec) 460 (mPa·sec) 200 (mPa·sec) 114 (mPa·sec) Novemer™ EC-1 polymer3 26,600 (mPa·sec) 20,500 (mPa·sec) 14,600 (mPa·sec) 6,880 (mPa·sec) 4,050 (mPa·sec) 2,300 (mPa·sec) 1 2 3 Sepigel® 3051 28,100 (mPa·sec) 14.73% 1.96% 0.69% 0.15% 0.11% Salcare® SC912 20,750 (mPa·sec) 35.37% 8.12% 2.22% 0.96% 0.55% Novemer™ EC-1 polymer3 26,600 (mPa·sec) 77.07% 54.89% 25.86% 15.23% 8.65% 1 2 3 Example 11 - Electrolyte Tolerance at Higher Polymer Solids Concentrations
Novemer™ EC-1 Polymer 2 wt. % 68,800 (mPa·sec) 68,000 (mPa·sec) 61,200 (mPa·sec) 46,000 (mPa·sec) 33,000 (mPa·sec) 24,450 (mPa·sec) 20,000 (mPa·sec) Salcare® SC91 2 wt. % 56,000 (mPa·sec) 15,560 (mPa·sec) 3,990 (mPa·sec) Fail Fail Fail Fail Sepigel® 305 2 wt. % 52,800 (mPa·sec) 6,290 (mPa·sec) 1,475 (mPa·sec) Fail Fail Fail Fail Simulgel® NS 2 wt. % 53,200 (mPa·sec) 8,650 (mPa·sec) 2,315 (mPa·sec) Fail Fail Fail Fail Fail: No substantial viscosity, or sample separates Example 12 - Comparative Yield Value in the Presence of Electrolyte
Novemer™ EC-1 Polymer 2 wt. % 5,210 5,740 4,200 3,230 2,830 2,870 2,240 Salcare® SC91 2 wt. % 3,550 874 134 Fail Fail Fail Fail Sepigel® 305 2 wt. % 3,550 325 NA Fail Fail Fail Fail Simulgel® NS 2 wt. % 3,770 598 115 Fail Fail Fail Fail Fail: No substantial viscosity, or sample separates Example 13 - Divalent Electrolyte Tolerance
Novemer™ EC-1 Polymer 1 wt % 28,250 (mPa·sec) 21,450 (mPa·sec) 14,360 (mPa·sec) 3,250 (mPa·sec) Salcare® SC91 1 wt. % 27,950 (mPa·sec) Fail Fail Fail Sepigel® 305 1 wt. % 19,300 (mPa·sec) Fail Fail Fail Fail: No substantial viscosity, or sample separates Example 14 - Emulsifying Properties
Deionized water 86.30 86.30 86.30 86.30 86.30 86.30 71.30 71.30 71.30 71.30 71.30 86.30 86.30 Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 Novemer™ EC-1 polymer (Noveon, Inc.) 3.70 3.70 3.70 3.70 3.70 3.70 3.70 3.70 3.70 3.70 3.70 3.70 3.70 Isopropyl Palmitate Estol® 1517/ Uniqema 10.00 Isopropyl Myristate Liponate® IPM/Lipo 10.00 Caprylic/ capric Triglycerides Crodamol® GTCC / Croda 10.00 Dimethicone DC® 200 (100 cSt)/ Dow Coming 10.00 Cyclo-methicone DC® 345 Dow Coming 10.00 Mineral Oil Drakeol® 21/ Penreco 10.00 Isohexadecane Arlamol® HD/ Uniqema Hydrogenated Polyisobutene Panalane® L14-E/ Lipo 10.00 Octylmethoxy cinnamate Heliopan® AV / H&R 10.0 0 Hydrogenated Castor oil 25.00 Sunflower Lipovol® 25.00 Seed Oil Sun / Lipo C12-14 Alkyl Benzoate Finsolv® TN / Finetex 25.00 Cetearyl Octanoate Crodamol® CAP/Croda 25.00 PPG-2 Myristyl Ether Propionate Crodamol® PMP / Croda 25.00 82C 30,800 30,400 29,050 29,700 27,650 28,850 27,050 30,450 26,500 29,850 16,900 30,600 23,750 82D 11,900 9,740 7,300 9,460 8,020 8,160 8,500 9,700 8,000 11,800 9,600 9,920 9,500 82E 3,320 2,460 3,940 3,400 1,940 4,060 1,920 3,080 3,040 3,020 1,980 2,940 1,740 82F 9,500 9,000 8,800 9,150 7,850 9,960 8,600 9,280 8,260 10,260 7,840 10,400 8,380 82H 7,600 8,400 5,760 9,140 6,200 8,540 8,700 9,640 7,360 8,500 7,680 10,860 7,600 82I 32,100 30,050 31,900 33,100 31,150 33,300 31,050 33,950 30,950 34,500 29,550 35,850 29,400 67F 27,900 N/A 33,000 N/A 30,800 N/A 28,500 N/A N/A N/A N/A N/A 22,500 67A 35,400 N/A 32,500 N/A 25,900 N/A 21,500 N/A N/A N/A N/A N/A 13,000 65B 37,300 N/A 38,300 N/A 35,200 N/A 34,050 N/A N/A N/A N/A N/A 28,300 65D 10,600 N/A 3,700 N/A 3,800 N/A 4,900 N/A N/A N/A N/A N/A 4,650 65F 19,300 N/A 24,150 N/A 14,350 N/A 10,000 N/A N/A N/A N/A N/A 4,800 84A 28,250 29,600 28,400 28,500 27,200 29,350 26,300 29,900 25,200 29,650 24,150 30,400 22,650 84B 28,650 28,550 23,450 28,300 25,000 29,800 19,050 28,750 19,250 24,950 16,550 29,300 14,600 Example 15 - Emulsification Properties Demonstrated
Deionized Water - 84.70 84.70 84.70 Glycerin 2.00 2.00 2.00 Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 Novemer™ EC-1 polymer (Noveon, Inc.) 2.00* Caprylic / Capric Triglyceride Liponate® GC (Lipo) 5.00 5.00 5.00 C12-14 Alkyl Benzoate Finsolv® TN (Finetex) 5.00 5.00 5.00 Dimethicone Dow Corning® DC 200 1.00 1.00 1.00 200 cP Fluid (Dow Coming) Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 Novemer™ EC-1 polymer (Noveon, Inc.) 2.00* Acrylates / Acrylamide / C12-30 Polyoxyalkylene (meth)acrylate Crosspolymer (and) Mineral Oil (and) Polysorbate 85 *Novemer™ EC-1 polymer (Noveon, Inc.) 2.00* Pheonoxyethanol Phenonip® (Clariant) 0.30 0.30 0.30 Polymer Added to Water Phase
Polymer Added to Oil Phase
Polymer Added to the Emulsion